StockDrifts LogoStockDrifts

Montanova Capital 13F Portfolio ยท Aaron Cowen

Portfolio Manager
Aaron Cowen
Performance
+27.47% (2026 Q2)
AUM (13F)
$5.47B
# of Holdings
95
Performance Rank
Allocation (Top 20)
67.72%
Latest filing
Q2 2026

Montanova Capital LLC Holdings Map

Top 50 Montanova Capital LLC Holdings

Top 10 holdings

StockCompany% Port.SharesValueActivityOwnershipAvg. CostDate
MANE
VERADERMICS INC
10.77%4.17M$512.5M
+0.00%(+0)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 4.17M shares2026-Q2: 4.17M shares
$63.15(+78.48%)
2026-06-30
ARQT
ARCUTIS BIOTHERAPEUTICS INC
6.85%12.44M$326.1M
+0.89%(+110.00K)
2025-Q2: 11.54M shares2025-Q3: 10.48M shares2025-Q4: 11.96M shares2026-Q1: 12.33M shares2026-Q2: 12.44M shares
$9.53(+174.82%)
2026-06-30
LEGN
LEGEND BIOTECH CORP
4.29%7.07M$204.2M
-6.74%(-511.03K)
2025-Q2: 3.77M shares2025-Q3: 3.82M shares2025-Q4: 6.61M shares2026-Q1: 7.58M shares2026-Q2: 7.07M shares
$32.72(-37.74%)
2026-06-30
PVLA
PALVELLA THERAPEUTICS INC NE
3.65%1.14M$173.5M
-1.57%(-18.09K)
2025-Q2: 714.5K shares2025-Q3: 822.4K shares2025-Q4: 892.4K shares2026-Q1: 1.15M shares2026-Q2: 1.14M shares
$43.87(+255.89%)
2026-06-30
AVBP
ARRIVENT BIOPHARMA INC
3.3%4.52M$156.9M
+2.60%(+114.45K)
2025-Q2: 3.41M shares2025-Q3: 3.70M shares2025-Q4: 4.11M shares2026-Q1: 4.40M shares2026-Q2: 4.52M shares
$20.06(+47.07%)
2026-06-30
BNTC
BENITEC BIOPHARMA INC
3.25%11.55M$154.5M
+0.00%(+0)
2025-Q2: 9.88M shares2025-Q3: 9.88M shares2025-Q4: 11.55M shares2026-Q1: 11.55M shares2026-Q2: 11.55M shares
$9.25(+35.73%)
2026-06-30
BHVN
BIOHAVEN LTD
3.22%10.29M$153.1M
+0.00%(+0)
2025-Q2: 5.62M shares2025-Q3: 5.62M shares2025-Q4: 10.29M shares2026-Q1: 10.29M shares2026-Q2: 10.29M shares
$18.79(-22.07%)
2026-06-30
AMD
ADVANCED MICRO DEVICES INC
3.14%257.2K$149.4M
+0.00%(+0)
2025-Q2: 398.8K shares2025-Q3: 398.8K shares2025-Q4: 389.6K shares2026-Q1: 257.2K shares2026-Q2: 257.2K shares
$93.47(+448.05%)
2026-06-30
RCUS
ARCUS BIOSCIENCES INC
3.09%4.78M$147.3M
-5.06%(-254.57K)
2025-Q2: 3.69M shares2025-Q3: 3.69M shares2025-Q4: 5.19M shares2026-Q1: 5.03M shares2026-Q2: 4.78M shares
$13.63(+116.27%)
2026-06-30
TSM
TAIWAN SEMICONDUCTOR MANUFAC
3.06%304.6K$145.5M
+1.98%(+5.92K)
2025-Q2: 300.4K shares2025-Q3: 277.2K shares2025-Q4: 271.4K shares2026-Q1: 298.7K shares2026-Q2: 304.6K shares
$126.35(+237.86%)
2026-06-30

About Montanova Capital LLCโ€™s portfolio

Montanova Capital LLC reports $5.47B in US-listed equity holdings across 95 positions in its most recent 13F filing. Its largest disclosed positions are MANE (10.8%), ARQT (6.8%) and LEGN (4.3%). The top 20 holdings account for 67.72% of reported assets. Its disclosed equity book has returned +98.97% on a three-year cumulative basis. Figures reflect the Q2 2026 filing.

Portfolio concentration

Portfolio concentration
MANE โ€” 11.5% ($512.53M)ARQT โ€” 7.3% ($326.10M)LEGN โ€” 4.6% ($204.18M)PVLA โ€” 3.9% ($173.51M)AVBP โ€” 3.5% ($156.87M)BNTC โ€” 3.5% ($154.52M)BHVN โ€” 3.4% ($153.07M)AMD โ€” 3.4% ($149.43M)RCUS โ€” 3.3% ($147.26M)TSM โ€” 3.3% ($145.48M)Other โ€” 52.4% ($2.33B)
48%in top 10
  • MANE11.5%
  • ARQT7.3%
  • LEGN4.6%
  • PVLA3.9%
  • AVBP3.5%
  • BNTC3.5%
  • BHVN3.4%
  • AMD3.4%
  • RCUS3.3%
  • TSM3.3%
  • Other52.4%

Portfolio changes

What the fund actually did

Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.

New buys
8
HUTHUT 8 CORP1.6%
APHAMPHENOL CORP1.0%
DKSDICKS SPORTING GOODS INC0.7%
AVGOBROADCOM INC0.7%
+4 opened
Added to
22
SNSEFAETH THERAPEUTICS INC+5747.1%
SPOTSPOTIFY TECHNOLOGY S A+9154.5%
IFRXINFLARX NV+189.1%
NVDANVIDIA CORPORATION+25.4%
+18 more
Trimmed
10
BACBANK OF AMER CORP-39.0%
GLUEMONTE ROSA THERAPEUTICS INC-16.0%
UNHUNITEDHEALTH GROUP INC-36.3%
LEGNLEGEND BIOTECH CORP-6.7%
+6 more

Unlock alerts, watchlists & AI chat

Sign up free to track Montanova Capital LLC, compare funds side by side, and get alerts the moment positions change.

Source filings

Holdings on this page are parsed from Montanova Capital LLCโ€™s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1569064). View Montanova Capital LLCโ€™s 13F filings on SEC

More 13F analyses

View all